Neuroendocrine Neoplasm
📧 Sign up to get email alerts when something new happens for Neuroendocrine Neoplasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-28Clinical Trial Results: Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with liver-directed therapy or peptide receptor radionuclide therapy for neuroendocrin…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer [Phase 1]
This Phase 1 trial update reports results for pembrolizumab combined with concurrent chemoradiotherapy or radiation therapy in small cell lu…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan [Phase 3]
Phase 3 open-label study evaluating [68Ga]Ga-DOTA-TATE PET imaging in patients with neuroendocrine neoplasms (and healthy volunteers) in Jap…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating cabozantinib (XL184) in combination with nivolumab and ipilimumab for poorly differentiated neuroendocrine tumors; …
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin. [Phase 2]
This is a phase 2 trial evaluating the combination of platinum-doublet chemotherapy with nivolumab for gastroenteropancreatic neuroendocrine…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-28Clinical Trial Update: Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating nintedanib in locally advanced or metastatic neuroendocrine tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: Chidamide Plus Sintilimab for Chemotherapy-refractory Advanced High-grade Neuroendocrine Neoplasm [Phase 2]
Phase 2 trial evaluating chidamide plus sintilimab in chemotherapy-refractory advanced high-grade neuroendocrine neoplasm; status not yet de…